Atlas Trials

Analysis of Sublingual Glycocalyx Damage at ICU Admission to Predict Risk of Death

Clinical trial NCT03847493 · UNKNOWN

Trial details

NCT number
NCT03847493
Sponsor
University Hospital Muenster
Status
UNKNOWN
Study type
OBSERVATIONAL
SepsisSeptic ShockEndothelial Dysfunction
Start date
2019-04-15
Primary completion
2022-12-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.